SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently trending as retail investors rally behind heavy institutional buying, with firms like Morgan Stanley significantly increasing their positions ahead of a busy schedule of oncology conferences. The market is hyper-focused on the company's REGAL clinical trial reaching 78 of 80 required events, fueling community speculation about a looming data readout and potential M&A activity.

T1 Energy, Inc. engages in developing battery solutions. It focuses on energy storage systems and commercial mobility. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

Technip Energies is capturing market attention as the company gains momentum with major engineering contracts and positive operational news, fueling community excitement about its growth in the U.S. manufacturing and energy infrastructure sector. Investors are closely monitoring the stock as sentiment shifts, with many actively discussing potential setups, analyst target revisions, and the company's positioning within the broader renewable energy and power grid evolution.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is currently trending due to a combination of heavy institutional scrutiny, ongoing AI monetization concerns following an analyst downgrade, and community debate over the company's valuation as a 'cash machine' versus its growth prospects. Investors are actively discussing the stock's potential as a long-term value play supported by a massive buyback program, while others fear that AI agents may disrupt its traditional subscription-based business model.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike Inc is experiencing intense selling pressure, with the stock trading at multi-year lows as market participants express deep skepticism over its turnaround efforts, leadership, and loss of market share. While some retail traders are betting on a recovery fueled by upcoming catalysts like the World Cup and potential tariff relief, many others are aggressively shorting the name, citing concerns over inventory, declining demand, and a perceived loss of brand resonance.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending as investors react to a new executive order aimed at fast-tracking psychedelic drug research and streamlining regulatory reviews through priority vouchers. The community is actively discussing the stock's role as a potential first-mover in the treatment-resistant depression market, with many focused on the upcoming release of pivotal trial data and speculation regarding long-term acquisition interest from major pharmaceutical players.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is facing significant volatility following a wider-than-expected net loss and missed revenue targets, though the companys raised forward guidance and strategic shift toward branded GLP-1 distributions have sparked debate. Community discourse remains deeply divided between those viewing the pullback as a buying opportunity based on long-term growth in peptides and personalized healthcare, and skeptics who remain concerned about margin compression and the sustainability of the company's valuation.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending as investors react to the launch of 'Ford Energy,' a new subsidiary focusing on battery energy-storage systems for data centers and industrial customers to capture AI-driven power demand. The community is actively debating whether this strategic pivot marks a valuation re-rating that transforms the legacy automaker into a high-growth AI infrastructure play.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is trending as the community actively debates its positioning in the Chinese AI and cloud infrastructure sector following mixed Q1 earnings and ongoing interest in its robotaxi and agentic AI initiatives. While some investors remain cautious about legacy ad revenue declines and geopolitical volatility, bullish sentiment persists around the company's long-term potential to capitalize on domestic AI demand and potential value realization from its subsidiary spinoffs.

Dominion Energy, Inc. engages in the production and distribution of energy. It operates through following business segments: Dominion Energy Virginia, Dominion Energy South Carolina, Contracted Energy, and Corporate and Other. The Corporate and Other segment focuses on corporate, service company, non-controlling interest in Dominion privatization, and non-regulated retail energy marketing operations. The company was founded by William W. Berry in 1983 and is headquartered in Richmond, VA.

Dominion Energy Inc

Dominion Energy is trending due to reports that NextEra Energy is in advanced talks to acquire the utility in a deal valued at approximately $66 billion, a move driven by the massive surge in electricity demand from AI and data center expansion. The community is actively debating the potential regulatory and antitrust hurdles for such a large-scale merger, while also discussing the impact on dividend consistency and the strategic fit of integrating Dominion's infrastructure into NextEra's portfolio.

LiveRamp Holdings, Inc. is a global technology company, which engages in the provision of a data collaboration platform in consumer privacy, data ethics, and foundational identity. The company was founded in 1969 and is headquartered in San Francisco, CA.

LiveRamp Holdings Inc

LiveRamp is trending following an acquisition agreement by Publicis, a move that the investment community is analyzing as a significant shift toward agency-owned data infrastructure. While some investors are debating the deal's valuation and the resulting arbitrage opportunities, many are actively discussing the broader implications for the ad-tech landscape and the impact on long-term shareholders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dermata Therapeutics Announces A Private Placement Valued At Up To $12.4 Mln

(RTTNews) - Dermata Therapeutics Inc. (DRMA), a dermatologic firm, announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 2.02 million shares of common...

Why Is Dermata Therapeutics Stock Surging Wednesday?

Dermata Therapeutics rose after announcing a private placement offering of common shares, Series C warrants, and Series D warrants.read more...

<ul class="summary-bullets"><li>The offering, alongside two series of warrants that permit future purchases of the same amount of shares, is priced at $2.04 per unit.&nbsp;</li><li>The company plans to use the proceeds for general corporate needs, including consumer research and rollout activities for its forthcoming over‑the‑counter acne kit.</li><li>In early December, Dermata said it is preparing to launch a fresh brand identity for its over-the-counter skincare line.</li></ul>Dermata Therapeutics, Inc. (DRMA) stock surged 22% in Wednesday’s premarket after the company announced that it has struck definitive agreements to issue roughly 2.02 million shares of its common stock in a private placement deal.&nbsp;The offering, alongside two series of warrants that permit future purchases of the same amount of shares, is priced at $2.04 per unit.&nbsp;<h2 class="st-heading-2">Use Of Proceeds</h2>Dermata expects roughly $4.1 million in gross proceeds initially, before fees and expenses. If all new warrants are exercised for cash, the number could rise by approximately $8.3 million, bringing total potential funding to nearly $12.4 million.&nbsp;The company plans to use the proceeds for general corporate needs, including consumer research, rollout activities for its forthcoming over‑the‑counter acne kit, licensing initiatives, possible strategic investments, and working capital.Following the announcement,&nbsp;<a href="https://stocktwits.com/symbol/DRMA">Dermata Therapeutics’ stock</a> traded over 24% higher in Wednesday’s premarket. On Stocktwits, retail sentiment around the stock jumped to ‘extremely bullish’ from ‘bearish’ territory the previous day. At the same time, message volume shifted to ‘extremely high’ from ‘extremely low’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:934/106;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_24_084540_png_7928eb6a71.webp" alt="DRMA’s Sentiment Meter and Message Volume as of 08:30 a.m. ET on Dec. 24, 2025 | Source: Stocktwits" width="934" height="106"><figcaption>DRMA’s Sentiment Meter and Message Volume as of 08:30 a.m. ET on Dec. 24, 2025 | Source: Stocktwits</figcaption></figure>Dermata creates science-based skin treatments with a focus on over-the-counter (OTC) skin products.&nbsp;<h2 class="st-heading-2">Dermata’s&nbsp;Skincare Line</h2>In early December, the company said it is preparing to launch a fresh brand identity for its over-the-counter skincare line, signaling a move toward a science-driven, direct-to-consumer model.&nbsp;Central to the rebrand is Dermata’s proprietary Spongilla technology, which is expected to enhance the efficacy of routine skincare. By simplifying regimens and boosting results, the products are designed to amplify the overall effectiveness of a skincare routine.The latest funding strategy with a fresh financing move is aimed at extending the runway for the company’s upcoming consumer skin‑care initiatives.&nbsp;DRMA stock has declined 84% year-to-date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/intel-s-manufacturing-push-faces-fresh-test-after-nvidia-passes-on-18-a-chips-report/cLesu73REv4">Intel’s Manufacturing Push Faces Fresh Test After Nvidia Passes On 18A Chips: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Did Dermata Therapeutics Stock Surge 22% Pre-Market Today?

The company has entered into definitive agreements to issue roughly 2.02 million shares of its common stock in a private placement deal. 

Equity

The company has entered into definitive agreements to issue roughly 2.02 million shares of its common stock in a private placement deal. 


Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.

Current Price	$1.19
Prev Close	$1.23
Open	$1.24
Dividend Yield	0.00%
50-Day Moving Average	$1.28
Beta	0.38
Avg. Volume	86,251.83
PE Ratio	-0.22

52-Week High	$8.50
52-Week Low	$1.10
Market Capitalization	$4.79M
EPS (Annual)	-$8.16
Price to Book	0.75
Revenue Per Employee	$0.00

DRMA
Dermata Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DRMA News

DRMADermata Therapeutics Inc